Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs VivoSim Labs, Inc. (VIVS)

Aptevo Therapeutics Inc. and VivoSim Labs, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and VivoSim Labs, Inc. are of similar size ($2.3M and $2.3M). Aptevo Therapeutics Inc. grew revenue faster over the last twelve months: 92.9% against −21.1%. Aptevo Therapeutics Inc. has the higher net margin (0.00% vs −11,016.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Aptevo Therapeutics Inc. leads on 8 and VivoSim Labs, Inc. on 8.

Valuation

Metric APVO VIVS Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 6.55 9.40
P/B 0.25 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 0.08 0.66
EV/Sales (0.37) (8.35) 9.02
Earnings yield (4,659.10%) (3,192.86%) (32.88%)
Free cash flow yield (1,718.19%) (164.43%) (23.13%)

Profitability

Metric APVO VIVS Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (10,116.96%) 0.00%
Net margin 0.00% (11,016.07%) 0.00%
Free cash flow margin 0.00% (1,014.29%) 0.00%
Return on equity (446.89%) (343.10%) (51.96%)
Return on assets (186.29%) (155.93%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO VIVS Biotechnology median
Revenue growth (TTM) 92.94% (21.13%) 6.76%
EPS growth (last fiscal year) 99.72% (214.71%) 29.88%
Revenue growth, 5-year CAGR (26.64%) (43.10%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO VIVS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 1.70 4.97
Net debt to EBITDA 0.83 0.45 1.01

Dividend

Metric APVO VIVS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APVO VIVS Biotechnology median
Market cap 2.30m 2.34m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack